Jack T Irwin

Title: Jack T. Irwin: Innovator in Pharmaceutical Formulations

Introduction

Jack T. Irwin is a notable inventor based in Kalamazoo, MI (US), recognized for his contributions to pharmaceutical formulations. With a total of 2 patents, he has made significant advancements in the field of drug release technologies.

Latest Patents

One of his latest patents is focused on "Tablets exhibiting reduced drug release variability." This invention describes a compressible extended-release tablet or tablet layer that maintains a consistent drug release profile, regardless of tablet hardness. The formulation involves dry blending a pharmaceutically active ingredient with hydroxypropyl methylcellulose, which has a bimodal or multimodal molecular weight distribution. This innovation allows for the preparation of tablet formulations without the need for wet granulation. Another significant patent is for "Pseudoephedrine hydrochloride extended-release tablets." This patent details a sustained-release hydroxypropylmethylcellulose matrix combined with a microcrystalline cellulose disintegrant, created through a dry mixed, direct compression method.

Career Highlights

Jack T. Irwin is currently associated with L. Perrigo Company, where he continues to develop innovative pharmaceutical solutions. His work has contributed to enhancing the efficacy and reliability of drug delivery systems.

Collaborations

Throughout his career, Jack has collaborated with esteemed colleagues such as Shirish A. Shah and Jaber G. Qasem, further enriching his research and development efforts.

Conclusion

Jack T. Irwin's innovative work in pharmaceutical formulations has led to significant advancements in drug release technologies. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.